Sexual disorders are common, distressing and multifactorial health problems which produce profound consequences in the life-quality of both men and women. In a general concept, sexual disorders comprise a group of diseases in which the individual or couple presents difficulties during any stage of a normal sexual activity, including desire, arousal or orgasm. In the last two decades, positive achievements have been reached and novel drugs were developed for the treatment of various sexual dysfunctions. Moreover, still there is a lack of options for several sexual dysfunctions and, recently, substantial efforts have been made in order to identify novel molecular targets. Indeed, the understanding and knowledge of sexual disorders have expanded enormously in terms of molecular pathophysiology, which may trigger to the development of novel drugs. This special issue encompasses a collection of reviews addressing recent advances in the pharmacotherapy for sexual disorders.
